A strict requirement for LBP in the TNFα hyper-response of propionibacterium acnes-sensitized mice to LPS

Journal of Endotoxin Research

Volumn 4, Issue 5, 1997, Pages 357-361

  Freudenberg, M A ^a   Gumenscheimer, M ^a   Jack, R ^b   Merlin, T ^a   Schutt C ^b   Galanos, C ^a  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL INFECTION; CYTOKINE PRODUCTION; FEMALE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROPIONIBACTERIUM ACNES; SENSITIZATION;

ANIMALIA; BACTERIA (MICROORGANISMS); CORYNEBACTERIUM; PROPIONIBACTERIUM ACNES;

EID: 0031450497     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199700400507     Document Type: Article

References (36)

1. Katschinski T., Galanos G., Coumbos A., Freudenberg M.A. Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect Immun 1992; 60: 1994-2001.
2. Morrison D.C., Ryan J.F. Bacterial endotoxins and host immune responses. Adv Immunol 1979; 28: 293-450.
3. Rosenstreich D.L., Vogel S.N. Central role of macrophages in the host response to endotoxin. In: Schlessinger D. (Ed) Microbiology. Washington, DC: American Society for Microbiology, 1980: 11-15.
4. Freudenberg M.A., Keppler D., Galanos C. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun 1986; 51: 891-895.
5. Vasalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992; 10: 411-452.
6. Galanos C., Freudenberg M.A., Katschinski T., Salomao R., Mossmann H., Kumazawa Y. Tumor necrosis factor and host response to endotoxin. In: Ryan J.L., Morrison D.C. (Eds). Bacterial Endotoxic Lipopolysaccharides, Immunopharmacology and Pathophysiology, Vol. 2. Boca Raton: CRC Press, 1992; 75-104.
7. Freudenberg M.A., Kopf M., Galanos C. Lipopolysaccharide-sensitivity of interferon-γ receptor deficient mice. J Endotoxin Res 1996; 3: 291-295.
8. Mathison J.C., Ulevitch R.J. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 1979; 123: 2133-2143.
9. Freudenberg M.A., Bøg-Hansen T.C., Back U., Galanos C. Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infect Immun 1980; 28: 373-380.
10. Tobias P.S., Ulevitch R.J. Control of lipopolysaccharide-high density lipoprotein by acute phase protein(s). J Immunol 1983; 131: 1913-1916.
11. Pugin J., Schürer-Maly C-C., Leturcq D., Moriarty A., Ulevitch R.J., Tobias P.S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993; 90: 2744-2748.
12. Tobias P.S., Soldau K., Gegner J.A., Mintz D., Ulevitch R.J. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem 1995; 270: 10482-10488.
13. Hailman E., Vasselon T., Kelley M. et al. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J Immunol 1993; 156: 4384-4390.
14. Yu B., Wright S.D. Catalytic properties of lipopolysaccharide (LPS) binding protein transfer of LPS to soluble CD14. J Biol Chem 1996; 211: 4100-4105.
15. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
16. Simmons D.L., Tan S., Tenen D.G., Nicholson-Weller A., Seed B. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood 1989; 73: 284-289.
17. Haziot A., Chen S., Ferrero E., Low M.G., Silber R., Goyert S.M. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 1988; 141: 547-552.
18. Ziegler-Heitbrock H.W.L., Ulevitch R.J. CD14: cell surface receptor and differentiation marker. Immunol Today 1993; 14: 121-125.
19. d and tumor necrosis factor receptor-deficient mice. Eur J Immunol 1996; 26: 2686-2692.
20. Heumann D., Gallay P., Barras C. et al. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J Immunol 1992; 148: 3505-3512.
21. Gallay P., Heumann D., Le Roy D., Barras C., Glauser M-P. Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock. Proc Natl Acad Sci USA 1993; 90: 9935-9938.
22. Gallay P., Heumann D., Le Roy D., Barras C., Glauser M-P. Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice. Proc Natl Acad Sci USA 1994; 91: 7922-7926.
23. Jack R.S., Fan X., Bernheiden M., Rune G. et al. Lipopolysaccharide-binding protein is required in vivo to combat a Gram negative bacterial infection. Nature 1997; In press.
24. Freudenberg M.A., Galanos C. Tumor necrosis factor alpha mediates lethal activity of killed Gram-negative and Gram-positive bacteria in D-galactosamine-treated mice. Infect Immun 1991; 59: 2110-2115.
25. Galanos C., Lüderitz O., Westphal O. Preparation and properties of a standardized lipopolysaccharide from Salmonella abortus equi (Novo-Pyrexal). Zentralbl Bakteriol Parasitenkd Infektionskr Hyg. Abt. 1 Orig. Reihe A 1979; 243: 226-244.
26. Grunwald U., Fan X., Jack R.S. et al. Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism. J Immunol 1996; 157: 4119-4126.
27. Aggarwal B.B., Kohr W.J., Hass P.E. et al Human tumor necrosis factor. Production, purification, and characterization. J Biol Chem 1985; 260: 2345-2354.
28. Freudenberg M.A., Galanos C. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immun 1988; 56: 1352-1357.
29. Schumann R.R., Leong S.R., Flaggs G.W. et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249: 1429-1431.
30. Ulevitch R.J., Tobias P.S. Receptor-mediated mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995; 13: 437-457.
31. Frey E.A., Miller D.S., Gullstein Jahr T. et al. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992; 176: 1665-1671.
32. Pugin J., Schürer-Maly C-C., Leturcq D., Moriarty A., Ulevitch R.J., Tobias P.S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993; 90: 2744-2748.
33. Hailman E., Vasselon T., Kelley M. et al. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J Immunol 1996; 156: 4384-4390.
34. Fearns C., Kravchenko V.V., Ulevitch R.J., Loskutoff D.J. Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide. J Exp Med 1995; 181: 857-866.
35. Matsuura K., Ishida T., Setoguchi M., Higuchi Y., Akizuki S., Yamamoto S. Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide. J Exp Med 1994; 179: 1671-1676.
36. Ferrero E., Jiao D., Tsuberi B.Z. et al. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 1993; 90: 2380-2384.